Exact Mass: 278.0361

Alcophosphamide

C7H17Cl2N2O3P (278.0354)

Detoxification of cyclophosphamide is effected, in part, by hepatic class 1 aldehyde dehydrogenase (ALDH-1)-catalyzed oxidation of aldophosphamide, a pivotal aldehyde intermediate, to the nontoxic metabolite, carboxyphosphamide. Detoxification of aldophosphamide may also be effected by enzymes, viz. Thus, NAD-linked oxidation and NADPH-linked reduction of aldophosphamide catalyzed by relevant erythrocyte enzymes were quantified. (PMID: 9394035) It has already been demonstrated that horse liver alcohol dehydrogenase catalyzes the reduction of aldophosphamide to alcophosphamide. (PMID: 8216347) D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards

Alcoifosfamide

C7H17Cl2N2O3P (278.0354)

Alcoifosfamide is a metabolite of ifosfamide. Ifosfamide (also marketed as Mitoxana and Ifex) is a nitrogen mustard alkylating agent used in the treatment of cancer. It is sometimes abbreviated IFO. (Wikipedia)

Cyclophosphamide monohydrate

C7H17Cl2N2O3P (278.0354)

D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents > D019653 - Myeloablative Agonists D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D009676 - Noxae > D000477 - Alkylating Agents D009676 - Noxae > D009153 - Mutagens D018501 - Antirheumatic Agents

(1,1-Diamino-4-sulfamoyloxybutyl) sulfamate

C4H14N4O6S2 (278.0355)

4',6-Dichloroflavan

C15H12Cl2O (278.0265)

Harmol sulfate

C12H10N2O4S (278.0361)

Nepenthone A

C13H10O7 (278.0427)

2-(4-Chlorophenyl)-1-(2,4,6-trihydroxyphenyl)ethanone

C14H11ClO4 (278.0346)

relative retention time with respect to 9-anthracene Carboxylic Acid is 1.081 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.080

DTXSID00803114

C13H10O7 (278.0427)

C13H10O7

C13H10O7 (278.0427)

C10H14O7S

C10H14O7S (278.046)

5-(4-acetoxy-1-butenyl)-2,2-bithienyl

C14H14O2S2 (278.0435)

Kurodainol

C10H15Cl2F3O (278.0452)

4,6-dihydroxy-9-methoxy-7-methylnaphtho<2,3-d>-1,3-dioxole-5,8-dione|nepenthone-A

C13H10O7 (278.0427)

Cribrarione A

C13H10O7 (278.0427)

MLS001306483-01!Cytoxan6055-19-2

C7H17Cl2N2O3P (278.0354)

Exifone

C13H10O7 (278.0427)

C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent CONFIDENCE standard compound; INTERNAL_ID 440; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2781; ORIGINAL_PRECURSOR_SCAN_NO 2779 CONFIDENCE standard compound; INTERNAL_ID 440; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2821; ORIGINAL_PRECURSOR_SCAN_NO 2820 CONFIDENCE standard compound; INTERNAL_ID 440; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2820; ORIGINAL_PRECURSOR_SCAN_NO 2819 CONFIDENCE standard compound; INTERNAL_ID 440; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2811; ORIGINAL_PRECURSOR_SCAN_NO 2809 CONFIDENCE standard compound; INTERNAL_ID 440; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2887; ORIGINAL_PRECURSOR_SCAN_NO 2885 CONFIDENCE standard compound; INTERNAL_ID 440; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2823; ORIGINAL_PRECURSOR_SCAN_NO 2822

CAY10464

C15H12Cl2O (278.0265)

Acecarbromal

C9H15BrN2O3 (278.0266)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

p-methoxyphenyl disulfide

C14H14O2S2 (278.0435)

6-chloro-2,2-dimethyl-4-(trifluoromethyl)chromen-7-ol

C12H10ClF3O2 (278.0321)

N-(2,4-DINITROANILINO)MALEIMIDE

C10H6N4O6 (278.0287)

3-AMINO-5-(4-NITROPHENYL)THIOPHENE-2-CARBOXYLIC ACID METHYL ESTER

C12H10N2O4S (278.0361)

5-BROMO-3-(PIPERIDIN-4-YL)-1H-INDOLE

C13H15BrN2 (278.0419)

6-BROMO-3-(PIPERIDIN-4-YL)-1H-INDOLE

C13H15BrN2 (278.0419)

(3,5,6-TRICHLORO-PYRIDIN-2-YL)-HYDRAZINE

C15H12Cl2O (278.0265)

Methyl 4-acetoxy-6-chloro-2-naphthoate

C14H11ClO4 (278.0346)

methyl 4-acetyloxy-8-chloronaphthalene-2-carboxylate

C14H11ClO4 (278.0346)

Ethyl 4-(2-Nitrophenyl)thiazole-2-carboxylate

C12H10N2O4S (278.0361)

4,4,5,5,6,6,7,7,7-Nonafluoroheptan-1-ol

C7H7F9O (278.0353)

3,3-DIFLUORO-[1,1-BIPHENYL]-4,4-DICARBOXYLIC ACID

C14H8F2O4 (278.0391)

Methyl 6-acetamido-4-chloroquinoline-2-carboxylate

C13H11ClN2O3 (278.0458)

5-Nitro-2-Furaldehyde (5-Nitrofurfurylene)Hydrazone

C10H6N4O6 (278.0287)

tetramine

C4H14N4O6S2 (278.0355)

4-[(4-chlorobenzoyl)amino]-1-methylpyrrole-2-carboxylic acid

C13H11ClN2O3 (278.0458)

(1Z)-(2,4-DIFLUOROPHENYL)-4-PIPERIDINYLMETHANONEOXIMEACETATE

C14H14O2S2 (278.0435)

Tipiracil hydrochloride

C9H12Cl2N4O2 (278.0337)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

silver neodecanoate

C10H19AgO2 (278.0436)

METHYL 3-HYDRAZINO-4-(PROPYLSULFONYL)THIOPHENE-2-CARBOXYLATE

C9H14N2O4S2 (278.0395)

4,4-DINITRO-[2,2-BIPYRIDINE] 1,1-DIOXIDE

C10H6N4O6 (278.0287)

ethyl 5-(4-chlorophenyl)-2-formyl-3-furoate

C14H11ClO4 (278.0346)

m-nitro-N-phenylbenzenesulphonamide

C12H10N2O4S (278.0361)

2-(4-Chloro-phenyl)-4-hydroxy-pyriMidine-5-carboxylic acid ethyl ester

C13H11ClN2O3 (278.0458)

1,2-Bis(phenylsulfinyl)ethane

C14H14O2S2 (278.0435)

Cartasteine

C9H14N2O4S2 (278.0395)

4-Chloro-6,7,8-trimethoxy-3-quinolinecarbonitrile

C13H11ClN2O3 (278.0458)

Ethyl 2-(4-nitrophenyl)thiazole-4-carboxylate

C12H10N2O4S (278.0361)

METHYL 3-HYDRAZINO-4-(ISOPROPYLSULFONYL)THIOPHENE-2-CARBOXYLATE

C9H14N2O4S2 (278.0395)

5-Chlorouridine

C9H11ClN2O6 (278.0306)

4-(5-CHLOROCARBONYL-FURAN-2-YL)-BENZOIC ACID ETHYL ESTER

C14H11ClO4 (278.0346)

ETHYL 8-FLUORO-4H-(1)-BENZOPYRANO(4 3-B&

C14H11FO3S (278.0413)

6-Bromo-1-cyclobutyl-3-ethyl-1H-indazole

C13H15BrN2 (278.0419)

ETHYL 4-(4-NITROPHENYL)THIAZOLE-2-CARBOXYLATE

C12H10N2O4S (278.0361)

2-bromo-6-butoxynaphthalene

C14H15BrO (278.0306)

2-(4-chloro-3,5-dimethylphenoxy)-3-nitropyridine

C13H11ClN2O3 (278.0458)

Benzoic acid,4-chloro-2-[(6-methoxy-3-pyridinyl)amino]-

C13H11ClN2O3 (278.0458)

Clofencet

C13H11ClN2O3 (278.0458)

FENTHION-OXON-SULFOXIDE

C10H15O5PS (278.0378)

5-Nitro-2-furfuraldazine

C10H6N4O6 (278.0287)

1-(2-chloropyrimidin-4-yl)-5-fluoro-3-methyl-1H-benzo[d]imidazol-2(3H)-one

C12H8ClFN4O (278.0371)

(Disulfanediyldi-4,1-phenylene)dimethanol

C14H14O2S2 (278.0435)

5-Bromo-1-cyclohexyl-1H-benzo[d]imidazole

C13H15BrN2 (278.0419)

4,4-Difluorobiphenyl-2,2-dicarboxylic acid

C14H8F2O4 (278.0391)

TERT-BUTYL ((3-BROMO-4,5-DIHYDROISOXAZOL-5-YL)METHYL)CARBAMATE

C9H15BrN2O3 (278.0266)

4-Methylbenzenesulfonothioic acid S-(4-methylphenyl) ester

C14H14O2S2 (278.0435)

potassium (3-fluoro-4-biphenyl)trifluoroborate

C12H8BF4K (278.0292)

Ethyl 4-(3-Nitrophenyl)thiazole-2-carboxylate

C12H10N2O4S (278.0361)

3-(6-CHLORO-PYRIDAZIN-3-YLOXY)-BENZOIC ACID ETHYL ESTER

C13H11ClN2O3 (278.0458)

1,6-Hexanediol bisphosphate

C6H16O8P2 (278.032)

3-Methyl-1,5-dithiophen-2-ylpentane-1,5-dione

C14H14O2S2 (278.0435)

4-(2-Hydroxyphenylsulfinyl)-butylphosphonic acid

C10H15O5PS (278.0378)

5-methyl-N-(4-nitrophenyl)-1-oxo-1lambda4-thiophene-2-carboxamide

C12H10N2O4S (278.0361)

N-(3-cyano-2-thiophenyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide

C11H10N4OS2 (278.0296)

6-[(3-methyl-5-nitro-1H-imidazol-3-ium-4-yl)sulfanyl]-7H-purine

C9H8N7O2S+ (278.046)

Alcophosphamide

C7H17Cl2N2O3P (278.0354)

D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards

Alcoifosfamide

C7H17Cl2N2O3P (278.0354)

methyl (2z)-4-[(3z)-5,6-dihydroxy-2-oxo-1-benzofuran-3-ylidene]-4-hydroxybut-2-enoate

C13H10O7 (278.0427)

3,4,9-trihydroxy-7-methoxy-2h,3h-naphtho[2,3-b]furan-5,8-dione

C13H10O7 (278.0427)

(2z)-4-{5-[(1e)-2-carboxyeth-1-en-1-yl]-2-hydroxyphenoxy}-4-oxobut-2-enoic acid

C13H10O7 (278.0427)

4,6-dihydroxy-9-methoxy-7-methyl-2h-naphtho[2,3-d][1,3]dioxole-5,8-dione

C13H10O7 (278.0427)

4-[5-(2-carboxyeth-1-en-1-yl)-2-hydroxyphenoxy]-4-oxobut-2-enoic acid

C13H10O7 (278.0427)

methyl 4-[(3z)-5,6-dihydroxy-2-oxo-1-benzofuran-3-ylidene]-4-hydroxybut-2-enoate

C13H10O7 (278.0427)

3,5,8-trihydroxy-7-methoxy-2h,3h-naphtho[2,3-b]furan-4,9-dione

C13H10O7 (278.0427)

4,6,7,8,12-pentahydroxy-10-methyl-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),5(13),6,8,10-pentaen-2-one

C13H10O7 (278.0427)

4,7-dihydroxy-9-methoxy-6-methyl-2h-naphtho[2,3-d][1,3]dioxole-5,8-dione

C13H10O7 (278.0427)